Zoetis | Les Charges D'Exploitation



Operating Expenses Changement Date
AbbVie USD 16.59B 5.96B 2024-12
Align Technology USD 851.07M 35.5M 2024-12
Bayer EUR 8.2B 5.59B 2024-12
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
Charles River Laboratories USD 1.17B 277.88M 2024-12
Dentsply International USD 1.41B 1000K 2024-12
Eli Lilly USD 8.38B 1.53B 2024-12
Henry Schein USD 3.04B 19M 2024-12
Idexx Laboratories USD 692.6M 20.95M 2024-12
Illumina USD 929M 590M 2024-12
IQVIA Holdings USD 3.33B 14M 2024-12
J&J USD 18.63B 500M 2024-12
Laboratory Of America USD 3.11B 85M 2024-12
Merck USD 11.33B 1.4B 2024-12
Neogen USD 215.56M 473.18M 2025-02
Pacira USD 162.55M 145.55M 2024-12
Patterson Companies USD 1.53B 109.77M 2025-01
Perrigo USD 1.03B 13.4M 2024-12
Pfizer USD 18.17B 5.63B 2024-12
Quest Diagnostics USD 2.26B 125M 2024-12
Sanofi EUR 10.07B 969M 2024-09
Sanofi EUR 6.77B 3.75B 2024-12
Zoetis USD 1.59B 71M 2024-12



Zoetis Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.